<
Interview with Dr. Gary Mezo
Friday January 25, 2002
By Sander Olson
Dr. Gary Mezo
NanobacLabs Researcher, Dr. Neva Ciftcioglu is currently at the NASA Johnson Space Center on a 1 year sabbatical doing nanobacterial research on the astronauts. It appears that nanobacteria “go wild” in zero gravity and the astronauts have an unusually high incidence of kidney stones, calcified coronary artery disease, arthritis and other disorders involving pathological calcification. NASA is more than just casually interested in finding out about these nanobacteria, especially since the geological discovery of finding nanobacteria in the martian Allende rock. For the purposes of this interview, I would like to downplay this aspect of research at this time. It is clearly “good press” and sensational, but the research is not done yet and we need to focus on the eradication of the human disease caused by these nanobacteria: Heart Disease, Kidney Disease and many others...
Questions by Sander Olson. Answers Dr. Gary Mezo.
Gary Mezo, PhD, ARNP, PAC, is a medical researcher who has spent the last decade doing groundbreaking work in the field of nanobacteria. Nanobacteria were discovered a decade ago, and are responsible for many human diseases. Dr. Mezo has developed a safe, effective method to destroy nanobacteria, called NanobacTX. You can find more information about him by going to the website: www.nanobaclabs.com.
Question 1: Tell us about how and when you discovered nanobacteria.
Our colleagues and Nobel Prize Nominee Medical Researchers, Neva Ciftcioglu, PhD and Olavi Kajander, MD, PhD, (Microbiology Department-University of Kuopio, Finland) were working on several medical research projects in 1992 using mammalian cell cultures. They became frustrated because their mammalian cell cultures kept dying. Mammalian cell cultures and most all human biologicals are normally grown in fetal bovine serum (FBS) and cell culture death is a common problem in medical research that forces researchers to start entire projects over again and again. Well, this time instead of just discarding the dead mammalian cell cultures, they just left them in the incubator and subsequently forgot about them. Approximately four months later finding the old cultures, they realized that an unusual thin slimy film had developed on the culture surfaces. Well, since scientists are by nature as inquisitive as cats, Drs. Ciftcioglu and Kajander they couldn’t resist full evaluation of this unusual slime. They were not able to determine the nature of the film using the highest power light microscopes, so they used Scanning Electron Microscopes and Transmission Electron Microscopes from lowest to highest magnification (100,000X). Lo and behold! They found these 20-200 nanometer sized nanobacteria in calcified shells: The bacteria in the stone! They had never seen anything like them, and nothing like them had ever been seen or described in the microbiology world. These nanobacteria are structurally and physiologically unique in many ways: they are 20-200 nanometers in size, they have a unique “cellular” structure and membrane structure like nothing else on earth, they replicate very slowly (every 3-5 days) and by different methods, they are pleomorphic meaning that they assume different life forms for different phases and activities of their lives, they can go dormant in a self-made calcium shell, they are saprophytic in humans, they are “the toughest of bugs” resistant to being killed both In-Vitro and In-Vivo and they are the cause of many human diseases. They are structurally and functionally simplistic, unbelievably small and genetically unique. Although nicked-named by one reporter as “Conan the Bacterium”, Drs. Ciftcioglu & Kajander formally named this novel pleomorphic nanobacteria that thrives in our blood, Nanobacterium sanguineum.
(More: Atomasoft News Source)
2002 © nanomagazine.com.
Dan
Interview with Dr. Gary Mezo . . .
